Drug Delivery to the Lungs Conference (DDL)

Drug Delivery to the Lungs Conference (DDL) is a premier international event focused on advancing respiratory science and sharing the latest innovations in inhalation therapy. Recognized as a leading European conference, DDL attracts scientists, academics, clinicians, regulators, and industry experts specializing in all facets of respiratory medicine development.

DDL is committed to covering every aspect of respiratory delivery, from early research and pharmacology to pre-clinical studies, chemistry manufacturing and controls (CMC), regulatory compliance, industrialization, and commercialization. The conference provides a friendly and informal environment for attendees to publish and present their work, engage with exhibitors, and discuss ideas with experts in the field. Drug Delivery to the Lungs Conference (DDL) is located at Primary: The Aerosol Society PO BOX 34 Portishead, BS20 7FE, GB.

As a not-for-profit conference, Drug Delivery to the Lungs Conference (DDL) reinvests surpluses into the research and training of future aerosol and drug delivery scientists. It strives to remain affordable for students, academic researchers, and scientists from all industry levels. We invite the management of Drug Delivery to the Lungs Conference (DDL) to create a customized and exclusive company showcase and product listing on our platform.